lavendamycin has been researched along with cytochrome c-t in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beall, HD; Behforouz, M; Cai, W; Gerdes, JM; Hassani, M; Holley, DC; Holloway, WG; Koelsch, KH; Lineswala, JP; Olang, F; Rose, AS | 1 |
1 other study(ies) available for lavendamycin and cytochrome c-t
Article | Year |
---|---|
Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cytochromes c; Drug Screening Assays, Antitumor; Humans; Models, Molecular; NAD(P)H Dehydrogenase (Quinone); Protein Binding; Streptonigrin; Structure-Activity Relationship | 2008 |